These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24589944)

  • 1. Lamivudine and Adefovir Motif Variants Detected in chronic Hepatıtıs B patients.
    Ozekinci T; Mese S; Ozbek E; Atmaca S
    Clin Ter; 2014; 165(1):13-7. PubMed ID: 24589944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [YMDD motif variants detected by Inno-Lipa HBV DR assay in chronic hepatitis B patients during lamivudine therapy].
    Arslan U; Ural O; Findik D
    Mikrobiyol Bul; 2008 Jul; 42(3):445-50. PubMed ID: 18822888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of chronic hepatitis B with primary adefovir resistance].
    Yamazhan T; Sertöz R; Pullukçu H; Taşbakan M; Ulusoy S; Erensoy S
    Mikrobiyol Bul; 2007 Apr; 41(2):297-301. PubMed ID: 17682718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevelance of common YMDD motif mutations in long term treated chronic HBV infections in a Turkish population.
    Alagozlu H; Ozdemir O; Koksal B; Yilmaz A; Coskun M
    Asian Pac J Cancer Prev; 2013; 14(9):5489-94. PubMed ID: 24175847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of rtN236T and rtA181V/T mutations associated with resistance to adefovir dipivoxil in samples from patients with chronic hepatitis B virus infection by the INNO-LiPA HBV DR line probe assay (version 2).
    Osiowy C; Villeneuve JP; Heathcote EJ; Giles E; Borlang J
    J Clin Microbiol; 2006 Jun; 44(6):1994-7. PubMed ID: 16757589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of resistance mutations in chronic hepatitis B patients receiving antiviral therapy for over one year].
    Aydoğan S; Ergünay K; Balaban Y; Alp A; Simşek H; Tatar G; Hasçelik G; Us D
    Mikrobiyol Bul; 2013 Jul; 47(3):472-81. PubMed ID: 23971924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of lamivudine-resistant mutational patterns with the antiviral effect of adefovir in patients with chronic hepatitis B.
    Cha CK; Kwon HC; Cheong JY; Cho SW; Hong SP; Kim SO; Yoo WD
    J Med Virol; 2009 Mar; 81(3):417-24. PubMed ID: 19152409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genotype distribution of chronic hepatitis B and hepatitis C patients and investigation of the resistance patterns in hepatitis B cases].
    Kalayci R; Altindiş M; Gülamber G; Demirtürk N; Akcan Y; Demirdal T
    Mikrobiyol Bul; 2010 Apr; 44(2):237-43. PubMed ID: 20549958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of hepatitis B virus to lamivudine restored by resistance to adefovir.
    Zaaijer HL; Takkenberg RB; Weegink CJ; Rebers SP; Menting S; Reesink HW; Schinkel J; Molenkamp R
    J Med Virol; 2009 Mar; 81(3):413-6. PubMed ID: 19152408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitive line probe assay that simultaneously detects mutations conveying resistance to lamivudine and adefovir.
    Hussain M; Fung S; Libbrecht E; Sablon E; Cursaro C; Andreone P; Lok AS
    J Clin Microbiol; 2006 Mar; 44(3):1094-7. PubMed ID: 16517902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A real-time PCR assay for the quantification of hepatitis B virus DNA and concurrent detection of YMDD motif mutations].
    Ağca H; Sayıner AA; Sengönül A; Simşek I; Akarsu M
    Mikrobiyol Bul; 2011 Oct; 45(4):664-76. PubMed ID: 22090297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low efficacy of entecavir therapy in adefovir-refractory hepatitis B patients with prior lamivudine resistance.
    Cho SW; Koh KH; Cheong JY; Lee MH; Hong SP; Yoo WD; Kim SO
    J Viral Hepat; 2010 Mar; 17(3):171-7. PubMed ID: 19678894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term adefovir dipivoxil monotherapy for up to 5 years in lamivudine-resistant chronic hepatitis B.
    Lee JM; Park JY; Kim DY; Nguyen T; Hong SP; Kim SO; Chon CY; Han KH; Ahn SH
    Antivir Ther; 2010; 15(2):235-41. PubMed ID: 20386079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid detection of lamivudine-resistant hepatitis B virus polymerase gene variants.
    Jardi R; Buti M; Rodriguez-Frias F; Cotrina M; Costa X; Pascual C; Esteban R; Guardia J
    J Virol Methods; 1999 Dec; 83(1-2):181-7. PubMed ID: 10598095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No resistance to tenofovir disoproxil fumarate through 96 weeks of treatment in patients with lamivudine-resistant chronic hepatitis B.
    Corsa AC; Liu Y; Flaherty JF; Mitchell B; Fung SK; Gane E; Miller MD; Kitrinos KM
    Clin Gastroenterol Hepatol; 2014 Dec; 12(12):2106-12.e1. PubMed ID: 24929235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of lamivudine- or adefovir-resistant hepatitis B virus mutations by a liquid array.
    Liu H; Mao R; Fan L; Xia J; Li Y; Yin Y; Li X; Zhao X; Guo H; Zhu H; Zhang Y; Kang Y; Zhang J
    J Virol Methods; 2011 Jul; 175(1):1-6. PubMed ID: 21513743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid re-emergence of YMDD mutation of hepatitis B virus with hepatic decompensation after lamivudine retreatment.
    Kwon SY; Choe WH; Lee CH; Yeon JE; Byun KS
    World J Gastroenterol; 2008 Jul; 14(27):4416-9. PubMed ID: 18666338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lamivudine and adefovir resistance in children and young adults with chronic hepatitis B.
    Akman SA; Kose S; Halicioglu O
    Int J Infect Dis; 2010 Mar; 14(3):e236-9. PubMed ID: 19665408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of primary and compensatory lamivudine resistance mutations in chronic hepatitis B virus-infected patients during long-term lamivudine treatment, assessed by a line probe assay.
    Libbrecht E; Doutreloigne J; Van De Velde H; Yuen MF; Lai CL; Shapiro F; Sablon E
    J Clin Microbiol; 2007 Dec; 45(12):3935-41. PubMed ID: 17913933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel accurate ACRS-PCR method with a digestion internal control for identification of wild type and YMDD mutants of hepatitis B virus strains.
    Hosseini SY; Sabahi F; Amini-Bavil-Olyaee S; Alavian SM; Merat S
    J Virol Methods; 2006 Nov; 137(2):298-303. PubMed ID: 16962669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.